CYP19A1 and ovarian hyperstimulation syndrome: Most of our patients had an antagonist stimulation protocol with or without aromatase inhibitors, and some of them had an ovulation trigger using the agonist alone or in combination with HCG, depending on the risk of ovarian hyperstimulation syndrome.